Pascaline Talmant

3.6k total citations
31 papers, 1.3k citations indexed

About

Pascaline Talmant is a scholar working on Hematology, Molecular Biology and Genetics. According to data from OpenAlex, Pascaline Talmant has authored 31 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Hematology, 13 papers in Molecular Biology and 12 papers in Genetics. Recurrent topics in Pascaline Talmant's work include Acute Myeloid Leukemia Research (19 papers), Chronic Lymphocytic Leukemia Research (10 papers) and Chronic Myeloid Leukemia Treatments (9 papers). Pascaline Talmant is often cited by papers focused on Acute Myeloid Leukemia Research (19 papers), Chronic Lymphocytic Leukemia Research (10 papers) and Chronic Myeloid Leukemia Treatments (9 papers). Pascaline Talmant collaborates with scholars based in France, Canada and Belgium. Pascaline Talmant's co-authors include Hervé Avet‐Loiseau, Richard Garand, Régis Bataille, Axelle Daviet, Nöel Milpied, Jean‐Luc Harousseau, Christophe Brigaudeau, Philippe Moreau, Éric Lippert and Jianyong Li and has published in prestigious journals such as Journal of Clinical Oncology, Blood and British Journal of Haematology.

In The Last Decade

Pascaline Talmant

30 papers receiving 1.3k citations

Peers

Pascaline Talmant
J W Vardiman United States
HG Ahuja United States
MA Bitter United States
Pascaline Talmant
Citations per year, relative to Pascaline Talmant Pascaline Talmant (= 1×) peers Ana Rasillo

Countries citing papers authored by Pascaline Talmant

Since Specialization
Citations

This map shows the geographic impact of Pascaline Talmant's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pascaline Talmant with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pascaline Talmant more than expected).

Fields of papers citing papers by Pascaline Talmant

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Pascaline Talmant. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pascaline Talmant. The network helps show where Pascaline Talmant may publish in the future.

Co-authorship network of co-authors of Pascaline Talmant

This figure shows the co-authorship network connecting the top 25 collaborators of Pascaline Talmant. A scholar is included among the top collaborators of Pascaline Talmant based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Pascaline Talmant. Pascaline Talmant is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Chevallier, Patrice, Nelly Robillard, Aude Charbonnier, et al.. (2012). Trastuzumab for treatment of refractory/relapsed HER2-positive adult B-ALL: results of a phase 2 GRAALL study. Blood. 119(11). 2474–2477. 11 indexed citations
2.
Borel, Cécile, Nicole Dastugue, Julien Mozziconacci, et al.. (2012). PICALM–MLLT10 acute myeloid leukemia: A French cohort of 18 patients. Leukemia Research. 36(11). 1365–1369. 35 indexed citations
3.
Mullier, François, Sylvie Daliphard, Richard Garand, et al.. (2011). Morphology, cytogenetics, and survival in myelodysplasia with del(20q) or ider(20q): a multicenter study. Annals of Hematology. 91(2). 203–213. 10 indexed citations
4.
Chevallier, Patrice, Beatrice Mahé, Richard Garand, et al.. (2008). Combination of chemotherapy and gemtuzumab ozogamicin in adult Philadelphia positive acute lymphoblastic leukemia patient harboring CD33 expression. International Journal of Hematology. 88(2). 209–211. 9 indexed citations
5.
Nguyen‐Khac, Florence, Élise Chapiro, Isabelle Radford‐Weiss, et al.. (2006). The t(14;19)(q32;q13) Translocation in B Lymphoproliferative Disorders: A Continuum from Chronic Lymphocytic Leukemia (CLL) to Marginal Zone Lymphoma (MZL)?.. Blood. 108(11). 4944–4944.
6.
Lessard, M, Stéphanie Struski, Vincent Leymarie, et al.. (2005). Cytogenetic study of 75 erythroleukemias. Cancer Genetics and Cytogenetics. 163(2). 113–122. 31 indexed citations
8.
Valle, Véronique Della, Paola Ballerini, Nicole Dastugue, et al.. (2004). Various types of rearrangements target TLX3 locus in T‐cell acute lymphoblastic leukemia. Genes Chromosomes and Cancer. 41(3). 243–249. 40 indexed citations
9.
Godon, Alban, Philippe Moreau, Pascaline Talmant, et al.. (2003). Is t(14;18)(q32;q21) a constant finding in follicular lymphoma? An interphase FISH study on 63 patients. Leukemia. 17(1). 255–259. 47 indexed citations
10.
Godon, Catherine, John H. Proffitt, Nicole Dastugue, et al.. (2002). Large deletions 5′ to the ETO breakpoint are recurrent events in patients with t(8;21) acute myeloid leukemia. Leukemia. 16(9). 1752–1754. 17 indexed citations
11.
Penther, Dominique, Claude Preudhomme, Pascaline Talmant, et al.. (2002). Amplification of AML1 gene is present in childhood acute lymphoblastic leukemia but not in adult, and is not associated with AML1 gene mutation. Leukemia. 16(6). 1131–1134. 34 indexed citations
12.
Garand, Richard, Surinder S. Sahota, Hervé Avet‐Loiseau, et al.. (2000). IgG‐secreting lymphoplasmacytoid leukaemia: a B‐cell disorder with extensively mutated VH genes undergoing Ig isotype‐switching frequently associated with trisomy 12. British Journal of Haematology. 109(1). 71–80. 11 indexed citations
13.
Godon, Catherine, et al.. (2000). Deletion of 5q31 is observed in megakaryocytic cells in patients with myelodysplastic syndromes and a del(5q), including the 5q- syndrome. Genes Chromosomes and Cancer. 29(4). 350–352. 6 indexed citations
14.
Avet‐Loiseau, Hervé, Christophe Brigaudeau, Nadine Morineau, et al.. (1999). High incidence of cryptic translocations involving the Ig heavy chain gene in multiple myeloma, as shown by fluorescence in situ hybridization. Genes Chromosomes and Cancer. 24(1). 9–15. 75 indexed citations
15.
Avet‐Loiseau, Hervé, Richard Garand, Fanny Gaillard, et al.. (1998). Detection of t(11;14) using interphase molecular cytogenetics in mantle cell lymphoma and atypical chronic lymphocytic leukemia. Genes Chromosomes and Cancer. 23(2). 175–182. 49 indexed citations
16.
Avet‐Loiseau, Hervé, Jianyong Li, Thierry Façon, et al.. (1998). High incidence of translocations t(11;14)(q13;q32) and t(4;14)(p16;q32) in patients with plasma cell malignancies.. PubMed. 58(24). 5640–5. 150 indexed citations
17.
Talmant, Pascaline, Françoise Méchinaud, Richard Garand, et al.. (1997). Comparative genomic hybridization is a powerful tool, complementary to cytogenetics, to identify chromosomal abnormalities in childhood acute lymphoblastic leukaemia. British Journal of Haematology. 99(3). 589–596. 21 indexed citations
18.
Talmant, Pascaline, et al.. (1996). Childhood B-cell acute lymphoblastic leukemia with FAB-L1 morphology and a t(9;11) translocation involving the MLL gene. PubMed. 38(3). 265–268. 8 indexed citations
19.
Duchayne, Éliane, Dominique Blanchard, Nelly Robillard, et al.. (1995). Minimally differentiated erythroleukaemia (AML M6 Variant'): a rare subset of AML distinct from AML M6. British Journal of Haematology. 90(4). 868–875. 48 indexed citations
20.
Moreau, Philippe, Pascaline Talmant, Nöel Milpied, et al.. (1991). TRISOMY 4 ASSOCIATED WITH ACUTE LYMPHOCYTIC LEUKAEMIA. British Journal of Haematology. 78(4). 576–576. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026